Critical determinants of the epilepsy treatment gap: A cross-national analysis in resource-limited settings

Epilepsia

Volumn 53, Issue 12, 2012, Pages 2178-2185

  Meyer, Ana Claire L ^a   Dua, Tarun ^b   Boscardin, W John ^c   Escarce, José J ^d   Saxena, Shekhar ^b   Birbeck, Gretchen L ^e,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Chikankata Health Services Epilepsy Care Team   (United States)

^f MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Cross national analysis; Epilepsy; Resource limited settings; Treatment gap

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ARTICLE; BIVARIATE ANALYSIS; ECONOMIC ASPECT; EPILEPSY; HEALTH CARE; HEALTH CARE UTILIZATION; HUMAN; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; POISSON DISTRIBUTION; POSTDOCTORAL EDUCATION; PRIORITY JOURNAL; RESOURCE ALLOCATION; RISK ASSESSMENT; RISK FACTOR; RURAL AREA; SYSTEMATIC REVIEW;

COMMUNITY HEALTH PLANNING; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DELIVERY OF HEALTH CARE; EPILEPSY; FEMALE; HEALTH RESOURCES; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALE;

EID: 84870621144     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12002     Document Type: Article

References (31)

1. Amoroso C, Zwi A, Somerville E, Grove N,. (2006) Epilepsy and stigma. Lancet 367: 1143-1144.
2. Anand S, Barnighausen T,. (2004) Human resources and health outcomes: cross-country econometric study. Lancet 364: 1603-1609.
3. Anand S, Barnighausen T,. (2007) Health workers and vaccination coverage in developing countries: an econometric analysis. Lancet 369: 1277-1285.
4. Baskind R, Birbeck GL,. (2005) Epilepsy-associated stigma in sub-saharan africa: the social landscape of a disease. Epilepsy Behav 7: 68-73.
5. Begley C, Baker G, Beghi E, Butler J, Chisholm D, Langfitt J, Levy P, Pachlatko C, Wiebe S, Donaldson K,; on behalf of the ILAE Commission on Healthcare Policy. (2007) Cross-country measures for monitoring epilepsy care. Epilepsia 48: 990-1001.
6. Bender D, Rivera T, Madonna D,. (1993) Rural origin as a risk factor for maternal and child health in periurban bolivia. Soc Sci Med 37: 1345-1349.
7. Birbeck GL,. (2000) Seizures in rural zambia. Epilepsia 41: 277-281.
8. Birbeck GL, Chomba E, Atadzhanov M, Mbewe E, Haworth A,. (2007) The social and economic impact of epilepsy in zambia: a cross-sectional study. Lancet Neurol 6: 39-44.
9. Brockerhoff M,. (1995) Child survival in big cities: the disadvantages of migrants. Soc Sci Med 40: 1371-1383.
10. Chisholm D,. (2005) Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis. Epilepsia 46: 751-759.
11. de Boer H, Mula M, Sander JW,. (2008) The global burden and stigma of epilepsy. Epilepsy Behav 12: 540-546.
12. Ding D, Wang W, Wu J, Ma G, Dai X, Yang B, Wang T, Yuan C, Hong Z, de Boer H, Prilipko L, Sander J,. (2006) Premature mortality in people with epilepsy in rural china: a prospective study. Epilepsia 5: 823-827.
13. Fotso J,. (2007) Urban-rural differentials in child malnutrition: trends and socioeconomic correlates in sub-saharan africa. Health Place 13: 205-223.
14. Global Health Observatory Data Repository. World Health Organization. http://apps.who.int/minerva/minerva.jsp?theme=downloads&vid=2100# (accessed July 23, 2012).
15. Hobcraft J, McDonald J, Rutstein S,. (1984) Socio-economic factors in infant and child mortality: a cross-national comparison. Popul Stud 38: 193-223.
16. Jacoby A, Snape D, Baker G,. (2005) Epilepsy and social identity: the stigma of a chronic neurological disorder. Lancet Neurol 4: 171-178.
17. Jilek-Aall L, Rwiza H,. (1992) Prognosis of epilepsy in a rural african community: a 30 year follow-up of 164 patients in an outpatient clinic in rural tanzania. Epilepsia 33: 645-650.
18. Kale R,. (2002) Global campaign against epilepsy: the treatment gap. Epilepsia 43 (Suppl. 6): 31-33.
19. Leonardi M, Ustun T,. (2002) The global burden of epilepsy. Epilepsia 43: 21-25.
20. Li L, Fernandes P, Noronha A, Marques L, Borges M, Borges K, Cendes F, Guerreiro C, Zanetta D, De Boer H, Espindola J, Miranda C, Prilipko L, Sander J,. (2007) Demonstration project on epilepsy in brazil: outcome assessment. Arq Neuropsiquiatr 65: 58-62.
21. Mani KS, Subbakrishna D,. (2003) Perspectives from a developing nation with special reference to rural areas. Epilepsia 44: 55-57.
22. Meyer A, Dua T, Ma J, Saxena S, Birbeck G,. (2010) Global disparities in the epilepsy treatment gap: a systematic review. Bull World Health Organ 88: 260-266.
23. Noronha A, Borges M, Marques L, Zanetta D, Fernandes P, De Boer H, Despindola J, Miranda C, Prilipko L, Bell G, Sander J, Li L,. (2007) Prevalence and pattern of epilepsy treatment in different socioeconomic classes in Brazil. Epilepsia 48: 880-885.
24. Sastry N,. (1997) What explains rural-urban differentials in child mortality in Brazil? Soc Sci Med 44: 989-1002.
25. Senior M, Williams H, Higgs G,. (2000) Urban-rural mortality differentials: controlling for material deprivation. Soc Sci Med 51: 289-305.
26. The Global Campaign against Epilepsy, World Health Organization, International Bureau for Epilepsy, International League Against Epilepsy. (2005) Atlas: epilepsy care in the world. The Global Campaign against Epilepsy, World Health Organization, International Bureau for Epilepsy, International League Against Epilepsy, Geneva. pp. 1-96.
27. The World Bank. (2006) World development indicators. International Bank for reconstruction and development. The World Bank, Washington, D.C., U.S.A.
28. The World Bank Group. PovcalNet Poverty Measures. http://iresearch. worldbank.org/PovcalNet/povcalNet.html (accessed July 23, 2012).
29. The World Bank Group. Quick Query of Selected World Development Indicators. http://databank.worldbank.org/ddp/home.do (accessed July 23, 2012).
30. Wang W, Wu J, Ma G, Dai X, Yang B, Wang T, Yuan C, Hong Z, Bell G, Prilipko L, de Boer H, Sander J,. (2006) Efficacy assessment of phenobarbital in epilepsy: a large community-based intervention trial in rural china. Lancet Neurol 5: 46-52.
31. World Health Organization, World Federation of Neurology. (2004) Atlas: country resources for neurologic disorders. World Health Organization, World Federation of Neurology, Geneva, pp. 1-62.